Bejelentkezés Regisztrálj ingyen

Cotinga Pharmaceuticals Működési árrés

Mi az Cotinga Pharmaceuticals Működési árrés?

A Működési árrés az Cotinga Pharmaceuticals, Inc. - 0.00%

Mi a Működési árrés meghatározása?



A működési árrés a működési bevételek aránya a nettó árbevétel és százalékban kifejezve.

Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.

Működési árrés a Health Care szektor a TSXV-on cégekben a Cotinga Pharmaceuticals -hoz képest

Mit csinál Cotinga Pharmaceuticals?

Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.

működési árrés -hoz hasonló cégek Cotinga Pharmaceuticals